Nirland Ltd

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
CDT Equity Inc. 13G CDT · 20678X502	CDT	20678X502	1.6%	75,315	13G	5/20/2026 Event 2/19/2026
Nirland Limited			1.6%	75,315
Stockton Limited			1.6%	75,315
The Rowland Master Trust			1.6%	75,315
Dovet Limited			1.6%	75,315
Conduit Pharmaceuticals Inc. 13G/A Amendment 1 CDT · 20678X106	CDT	20678X106	0%	0	13G/A Amendment 1	2/20/2025 Event 2/19/2025
Nirland Limited			0%	0
Stockton Limited			0%	0
The Rowland Master Trust			0%	0
Dovet Limited			0%	0
Conduit Pharmaceuticals Inc. 13G CDT · 20678X106	CDT	20678X106	10.0%	15,350,000	13G	1/21/2025 Event 1/13/2025
Nirland Limited			10.0%	15,350,000
Stockton Limited			10.0%	15,350,000
The Rowland Master Trust			10.0%	15,350,000
Dovet Limited			10.0%	15,350,000

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.